New US Administration: Looming Tariffs on Pharma Timelines

New US Administration: Looming Tariffs on Pharma Timelines

Summary

Within the first 100 days of the current US Administration, there has been a clear shift toward more protectionist trade policy. The 47th US President has implemented a series of tariff measures aimed at reducing the trade deficit.

To date, key outcomes have included -

  • Imposition of a 10% global baseline tariff
  • Introduction of a reciprocal tariff framework
  • Significant tariffs on strategic sectors such as steel, aluminum, and automotive
  • Heightened tensions between the US and China
Scope
  • This report examines the transition of the 47th U.S. Administration toward a protectionist trade policy during its first 100 days.
The analysis focuses on efforts to reduce the trade deficit while assessing the broader implications for domestic industry and global trade relations.


Brief Introduction to tariffs
Timeline of looming tariffs for Pharma
Appendices
Related Reports
About GlobalData
How to contact us

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings